Answers are grounded in this paper and cite their sources.
Case report describes sugammadex safely reversing neuromuscular blockade in a myasthenia gravis patient during thymectomy, indicating effective management in high-risk anesthesia.
Myasthenia gravis (MG) is an autoimmune neuromuscular disorder characterized by muscle weakness. Surgical management of myasthenic patients requires careful perioperative planning to minimize the risks associated with anesthesia and surgery. Neuromuscular blocking agents (NMBAs) predispose such patients to post-operative residual paralysis and respiratory complications. One critical aspect is the reversal of neuromuscular blockade. Sugammadex, a modified γ-cyclodextrin, reverses the effects of steroidal NMBAs and is not accompanied by the risk of triggering a cholinergic crisis, a potential complication with cholinesterase inhibitors. We report the perioperative management of a 56-year-old female with MG undergoing thymectomy.
No takes yet. Share an insight, caveat, or question.
Lohanathan et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: